Entities sign Memorandum of Understanding to cultivate best-in-class clinical research services for Alzheimer’s and other neurodegenerative diseases.

First-of-its-kind database, supported by Alzheimer's Drug Discovery Foundation, will provide greater access to key data on Alzheimer’s to researchers around the world.

Alzheimer’s treatment studies offer hope as UNLV expert predicts new potential drugs, biomarkers will yield critical insight for future development.

Amanda Osse is the first recipient of the award named in honor of Nathan Lindsay, who passed away after a 15-year battle with Alzheimer's disease.

Annual review of current Alzheimer’s clinical trials reveals trends in design, therapies, outcomes, and funding surrounding work to develop new treatments.
 

UNLV expert Dr. Jeffrey Cummings explains how a new lab expands UNLV's neuroscience research capabilities.

UNLV researchers made international headlines this year with their discoveries. Here's a roundup of some of our top stories of 2021.

UNLV research professor Jeffrey L. Cummings examines Alzheimer's clinical trials pipeline in two new studies.